BSE filing, NSE: NAUKRI. Summary written from the filing by ALFA Finder's alert engine.
Info Edge (India) Ltd: key numbers
- Share price
- ₹1,173.00
- Market cap
- ₹76,060 Cr
- Revenue (annual)
- ₹3,285 Cr
- Net profit (annual)
- ₹1,450 Cr
- P/E (TTM)
- 43.1×Sector 61.5×
- Promoter holding
- 37.19%-0.28% QoQ
- FII holding
- 25.46%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Info Edge (India) Ltd
All →Info Edge (India) Earnings Call Transcript: Key Takeaways
Info Edge delivers strong standalone billing growth of 13% while announcing the major exit of long-time CEO Hitesh Oberoi. The core recruitment business remains steady, and real estate portal 99acres has pivoted to positive cash generation.
- Call
- Guides 15% growth
Info Edge (India) Acquisition Worth ₹150 Cr
Info Edge agreed to invest up to Rs.150 Crore in wholly-owned subsidiary Redstart Labs (India) Limited via equity shares in tranches. Redstart remains a wholly-owned subsidiary after the investment.
- Value
- ₹150.0 Cr
- Execution
- Within 18 months from the approval
Info Edge (India) Dividend
Info Edge declared an interim dividend of Rs 3 per share for FY2026-27. Record date is 6 November 2026, with payment by 23 November 2026.
Info Edge (India) Management Change
Info Edge board approved Hitesh Oberoi stepping down as MD and CEO from December 2, 2026, taking a Non-Executive director role. Sanjeev Bikhchandani is appointed Executive Vice Chairman, MD and Group CEO from December 3, 2026.
Info Edge (India) Merger & Restructuring Worth ₹0 Cr
Info Edge approved divestment of fully impaired Medcords and Unnati Online stakes for nominal consideration. Both transactions expected to complete by January 2027.
- Value
- ₹0.00 Cr
Info Edge (India) Q2 FY27 Results: Net Profit ₹649.8 Cr, Up 87.0% YoY
Info Edge (India) Ltd reported revenue from operations of ₹903.9 Cr (+12.2% YoY) and net profit of ₹649.8 Cr (+87.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹649.8 Cr · +87.0% YoY
Other employee stock options announcements
All →Strides Pharma Science Employee Stock Options
Strides Pharma allotted 7,500 equity shares to an employee exercising options under the Strides ESOP 2016 Plan. Paid-up capital rises to 92,180,214 shares.
Shaily Engineering Plastics Employee Stock Options
Shaily Engineering Plastics allotted 1,300 equity shares to employees on exercise of ESOPs at Rs. 732 per share under its 2019 plan. Issued paid-up capital rises to 4,59,96,548 shares of Rs. 2 each.
Motilal Oswal Financial Services Employee Stock Options
Motilal Oswal Financial Services granted 2,20,000 stock options to eligible employees under its ESOP Scheme X. No exercise price or monetary value is disclosed.
Borosil Employee Stock Options
Borosil granted 7,23,200 employee stock options at Rs 192.8 each under its 2020 scheme. Options vest in three tranches over three years.
- Execution
- Vesting over 3 years from grant date
Natco Pharma Employee Stock Options
Natco Pharma's insiders, including promoters and directors, were allotted equity shares. This allotment increases their total shareholding in the company.
- Value
- ₹144.2 Cr
Coforge Employee Stock Options
Coforge allotted 24,242 equity shares under its ESOP (2005) scheme on 29 October 2026. Paid-up capital rises to 44,30,62,864 equity shares.